Cymbalta and Biliary tract disorder - a phase IV clinical study of FDA data

Summary:

Biliary tract disorder is reported as a side effect among people who take Cymbalta (duloxetine hydrochloride), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Lorazepam, and have Sleep disorder.

The phase IV clinical study analyzes which people have Biliary tract disorder when taking Cymbalta. It is created by eHealthMe based on reports of 145,249 people who have side effects when taking Cymbalta from the FDA, and is updated regularly.

What is Cymbalta?

Cymbalta has active ingredients of duloxetine hydrochloride. It is often used in depression. eHealthMe is studying from 154,973 Cymbalta users. Check the latest studies of Cymbalta.

What is Biliary tract disorder?

Biliary tract disorder is found to be associated with 286 drugs and 401 conditions by eHealthMe. Check the latest studies of Biliary tract disorder.

On Jul, 30, 2026

145,249 people reported to have side effects when taking Cymbalta.
Among them, 20 people (0.01%) have Biliary tract disorder.

Could Cymbalta cause Biliary tract disorder?

Among these 20 people:

How long have people been on Cymbalta when they have Biliary tract disorder? *

What is the gender of people who have Biliary tract disorder when taking Cymbalta? *

female: 80 %
male: 20 %

What is the age of people who have Biliary tract disorder when taking Cymbalta? *

What are other drugs people take besides Cymbalta? *

What are other side effects people have besides Biliary tract disorder? *

Fatigue (feeling of tiredness): 7 people, 35.00%
Nausea (feeling of having an urge to vomit): 7 people, 35.00%
Abdominal Pain: 6 people, 30.00%
Diarrhea: 5 people, 25.00%
Urinary Tract Infection: 5 people, 25.00%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 5 people, 25.00%
Alanine Aminotransferase Increased: 5 people, 25.00%
Indigestion: 5 people, 25.00%
Pain: 5 people, 25.00%
Hepatotoxicity (chemical-driven liver damage): 4 people, 20.00%

What are the existing conditions these people have? *

Sleep Disorder: 4 people, 20.00%
Viith Nerve Paralysis: 3 people, 15.00%
Panic Disorder: 3 people, 15.00%
Constipation: 3 people, 15.00%
Indigestion: 3 people, 15.00%
Pain: 3 people, 15.00%
Abdominal Discomfort: 3 people, 15.00%
Post-Traumatic Stress Disorder: 3 people, 15.00%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 10.00%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cymbalta and have Biliary tract disorder?

- Check whether Biliary tract disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cymbalta:

Cymbalta (154,973 reports)

Browse all side effects of Cymbalta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Biliary tract disorder:

Biliary tract disorder (286 drugs)

Browse all the conditions that are associated with Biliary tract disorder:

Biliary tract disorder (401 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on duloxetine hydrochloride (the active ingredients of Cymbalta) and Cymbalta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.